Literature DB >> 7842211

Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects.

M Saetta1, P Maestrelli, G Turato, C E Mapp, G Milani, F Pivirotto, L M Fabbri, A Di Stefano.   

Abstract

To determine whether the cessation of exposure to isocyanates is associated with structural changes of the airway wall in sensitized subjects, we studied bronchial biopsies from 10 subjects with occupational asthma induced by toluene diisocyanate (TDI). Bronchial challenges with TDI and methacholine were performed and biopsies were taken on two occasions, at diagnosis and 6 to 21 mo after cessation of exposure to TDI. After bronchoscopy, biopsies were formalin-fixed or snap-frozen in liquid nitrogen and then processed for a quantitative histochemical and immunohistochemical analysis. After cessation of exposure, we observed a significant decrease of the sensitivity to TDI (p < 0.05), of the thickness of subepithelial fibrosis (p < 0.007), and of the numbers of subepithelial fibroblasts (p < 0.05), mast cells (p < 0.02), and lymphocytes (p < 0.03) as compared with values at diagnosis. By contrast, the nonspecific bronchial hyperresponsiveness and the numbers of macrophages and eosinophils did not change. In conclusion, in patients with occupational asthma induced by TDI, the cessation of exposure to the sensitizing agent is associated with a reduced thickness of subepithelial fibrosis and with a reduced number of subepithelial fibroblasts, mast cells, and lymphocytes in the bronchial mucosa, suggesting a remodeling of the airway wall with the avoidance of the specific stimulus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7842211     DOI: 10.1164/ajrccm.151.2.7842211

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  Airway remodeling in asthma.

Authors:  J A Elias; Z Zhu; G Chupp; R J Homer
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics.

Authors:  Firuz Capraz; Erdogan Kunter; Hakan Cermik; Ahmet Ilvan; Suheyl Pocan
Journal:  Lung       Date:  2007-03-28       Impact factor: 2.584

Review 3.  Occupational asthma due to isocyanates.

Authors:  X Baur
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 4.  Outcome of occupational asthma after cessation of exposure: a systematic review.

Authors:  George Rachiotis; Rashna Savani; Andrew Brant; Stephanie J MacNeill; Anthony Newman Taylor; Paul Cullinan
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

5.  Biological characteristics of tracheal smooth muscle cells regulated by NK-1R in asthmatic rat with airway remodeling.

Authors:  Bing Wei; Yali Liu; Xiaozhe Yue; Yinping Li; Yunxiao Shang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure.

Authors:  G Pisati; A Baruffini; F Bernabeo; S Cerri; A Mangili
Journal:  Int Arch Occup Environ Health       Date:  2006-09-07       Impact factor: 3.015

Review 7.  Pathogenesis and disease mechanisms of occupational asthma.

Authors:  Zana L Lummus; Adam V Wisnewski; David I Bernstein
Journal:  Immunol Allergy Clin North Am       Date:  2011-11       Impact factor: 3.479

8.  Long term outcome of soybean epidemic asthma after an allergen reduction intervention.

Authors:  J M Antó; J B Soriano; J Sunyer; M J Rodrigo; F Morell; J Roca; R Rodríguez-Roisín; M C Swanson
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

9.  Diagnosis and prevention of diseases induced by isocyanate.

Authors:  Kazuko Nakashima; Tatsuya Takeshita; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

Review 10.  Allergen-induced airway remodelling.

Authors:  C M Lloyd; D S Robinson
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.